About Atomic alchemy

About company

Atomic Alchemy came from a problem that has been intensifying in the United States for decades: There is currently no dedicated domestic supplier for medical radioisotopes, such as Molybdenum-99. The United States is the largest consumer of radiopharmaceuticals in the world, yet produces a fraction of demand with university research reactors. While there is nothing inherently wrong with sourcing material from abroad, geopolitical issues with suppliers (Russia) or natural events (air freight disruptions due to volcanic eruptions) have caused--and will continue to cause--severe shortages (up to 50,000 procedures a day!) until a reliable, domestic supply from the private sector is established.